Organic Active Ingredients TRIZ Cases

Allosteric M4 modulators boost central receptor activity while avoiding peripheral cholinergic effects linked to non-selective treatments.

A spiro eIF2B activator weakens the integrated stress response to restore protein synthesis and address ALS-related protein homeostasis.

CRISPR/Cas targeting of the LDHA gene lowers oxalate production in hyperoxaluria while helping prevent kidney damage and preserve liver function.

Controlled hydroxide and high HA concentration improve cross-linker use, gel strength, and biocompatibility in cross-linked HA gels.

Formula 1 compounds suppress glial activation biomarkers and maintain cellular homeostasis to limit neuronal damage in CNS disorders.

A temperature-responsive UPy-PEG hydrogel stays injectable, then gels in the peritoneal cavity to prolong drug exposure and reduce systemic toxicity.

Structural changes to 5-MeO-DMT shift receptor activity toward 5-HT1A to preserve anxiolytic and antidepressant effects with lower hallucinogenic potential.

Alumina chromatography and solvent precipitation refine hydroxypropyl beta-cyclodextrin for chronic intrathecal dosing with fewer impurity risks.

Recombinant E. coli fermentation and nanofiltration replace costly synthesis steps to deliver scalable, high-purity cyclic dinucleotides.

A single GnRH antagonist injection resets follicular wave emergence at a consistent time, simplifying fixed-time reproductive protocols.

Kinetic control of nucleic acid/lipid assembly tunes LNP size for reproducible yield, shelf stability, and stronger in vitro and in vivo transfection.

Two separate aripiprazole depot injections plus one oral dose reach therapeutic plasma levels faster and avoid 14-day oral supplementation.

Converting high-content nicotine oil into a crystalline fumarate salt improves handling, stability, and water solubility for product formulation.

Dual inhibition with GDC-6036 and inavolisib treats KRAS G12C cancers while avoiding PIK3CA pretesting and helping delay resistance.

Effervescent flotation and a hydrophilic matrix keep the anaesthetic in the stomach longer for sustained release and reduced early satiety.

Ligand-conjugated siRNA targets SLC25A5/ANT2 to suppress adipogenesis and improve metabolic parameters in NAFLD and obesity.

Iron and citrate added to photoactivated riboflavin accelerate corneal cross-linking, enabling faster, more controlled stiffening.

Brain-mimicking 3D hydrogels improve Alzheimer’s drug screening by modeling human tissue and identifying PI3K inhibitors that lower Aβ and pTau.

Structural changes to camptothecin ADC payloads improve plasma stability, tumor-cell inhibition, bystander effect, and in vivo targeting.

Controlled crystallization of evenamide hydrochloride forms I and II improves stability, solubility, and storage for pharmaceutical formulations.

Direct eye-drop delivery of naphthylurea compounds improves corneal neovascularization treatment consistency and sustained inhibition.

Targeted APOL1 inhibitor compounds address FSGS and NDKD progression while avoiding the broad side effects of corticosteroids.

A modular Fascin1 inhibitor composition simplifies synthesis while suppressing cancer cell invasion, metastasis, and metastatic colonization.

Staggering vaccination before and during immunosuppressive therapy helps preserve efficacy while lowering infection risk in autoimmune care.

Functional fibers, probiotics, and metabolic cofactors help pets lose weight while improving satiety, metabolism, and nutrient sufficiency.

Combining chlorphenesin with hydroxychloroquine inhibits cancer metastasis and invasion with synergistic effect and low cytotoxicity.

Chemoenzymatic 3-O-sulfation creates synthetic heparin oligosaccharides with fast clearance, effective anticoagulation, and lower bleeding risk.

Condensed mesenchymal cell bodies in a hydrogel enable minimally invasive cartilage and connective tissue repair with host tissue integration.

Balanced osmolality at 280-320 mosmol/kg helps this solid beverage replenish electrolytes quickly while reducing gastric retention and nausea.

Substituted bicyclic heterocyclic compounds target the underlying cause of Huntington's disease, expanding small-molecule treatment options.

Combining AAV-delivered micro-dystrophin with miR-29 reduces fibrosis barriers while restoring muscle strength in muscular dystrophy.

Compounds that lower HIF1α, lactate, and ATP target Warburg-driven resistant cancers and boost biguanide efficacy without lactic acidosis.

Stable crystalline GLP-1R agonist forms replace moisture-sensitive amorphous material, improving oral formulation and manufacturability.

Non-aqueous medium-chain triglycerides dissolve poorly water-soluble avacopan for stable oral dosing in pediatric and swallowing-impaired patients.

A 2-42 day washout or reduced CYP3A4 substrate dosing after posaconazole helps avoid dangerous accumulation-related side effects.

Self-assembling vesicles and silica sealing protect stored DNA from heat, enzymes, radiation, and chemical degradation.

A drug combination of (R)-oxybutynin and an NRI activates pharyngeal muscles during sleep to reduce airway collapse and improve OSA control.

Polymethine dye functionalization enables OATP-mediated uptake of nanocarriers in SLCO-altered adenocarcinoma cells while limiting healthy-tissue exposure.

A pan-PPAR agonist activates PPARα, PPARβ/δ, and PPARγ to improve metabolic control while addressing efficacy limits and side effects.